Ligne de temps
Isabelle Rosinski-Chupin
page
15 mai 2024
publication
An antiplasmid system drives antibiotic resistance gene integration in carbapenemase-producing Escherichia coli lineages.
Lire plus25 avr. 2023
publication
A Novel CovS Variant Harbored by a Colonization Strain Reduces Streptococcus pyogenes Virulence.
Lire plus11 janv. 2022
publication
Specificities and Commonalities of Carbapenemase-Producing Escherichia coli Isolated in France from 2012 to 2015.
Lire plus01 sept. 2021
publication
The CovR regulatory network drives the evolution of Group B Streptococcus virulence.
Lire plus01 juin 2021
publication
Evolution of VIM-1-Producing Klebsiella pneumoniae Isolates from a Hospital Outbreak Reveals the Genetic Bases of the Loss of the Urease-Positive Identification Character.
Lire plus27 oct. 2020
publication
Diversity of mucoid to non-mucoid switch among carbapenemase-producing Klebsiella pneumoniae.
Lire plus20 janv. 2020
publication
Stepwise evolution and convergent recombination underlie the global dissemination of carbapenemase-producing Escherichia coli.
Lire plus22 mars 2019
publication
Conserved and specific features of Streptococcus pyogenes and Streptococcus agalactiae transcriptional landscapes.
Lire plus15 oct. 2018
publication
A 4.5-Year Within-Patient Evolution of a Colistin-Resistant Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Sequence Type 258.
Lire plus01 janv. 2018
publication
Transcriptional Landscape of a blaKPC-2 Plasmid and Response to Imipenem Exposure in Escherichia coli TOP10.
Lire plus05 sept. 2017
publication
Parallel Evolution of Group B Streptococcus Hypervirulent Clonal Complex 17 Unveils New Pathoadaptive Mutations.
Lire plus29 août 2016
17 août 2015
publication
Whole-Genome Comparison Uncovers Genomic Mutations between Group B Streptococci Sampled from Infected Newborns and Their Mothers
Lire plus30 mai 2015
publication
Single nucleotide resolution RNA-seq uncovers new regulatory mechanisms in the opportunistic pathogen Streptococcus agalactiae.
Lire plus04 août 2014
publication
Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline.
Lire plus04 août 2014
publication
Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline.
Lire plus01 sept. 2012
publication